U.S. Markets open in 5 hrs 11 mins

Gene Therapy Pipeline May Drive Rocket Pharmaceuticals’ Growth

Margaret Patrick
Gene Therapy Pipeline May Drive Rocket Pharmaceuticals’ Growth

Rocket Pharmaceuticals (RCKT) is a clinical-stage biopharmaceutical company focused on advancing its early-stage gene therapy pipeline across multiple rare diseases with significant unmet demand. According to Rocket Pharmaceuticals, the company’s leading ex-vivo lentiviral vector program in the FA indication is currently in the clinical stage of development. Other research programs are either in the preclinical stage or the discovery stage.